-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
A new SAS macro for flexible parametric survival modeling: applications to clinical trials and surveillance data
Ron Dewar & Iftekhar Khan
Review Article: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation
-
Translational biomarker in early oncology clinical development: decision case study for MEK inhibitors in healthy volunteer studies
Lucy Lee
Special Report: Clinical Investigation